Ignite Creation Date:
2025-12-24 @ 2:28 PM
Ignite Modification Date:
2026-02-25 @ 11:48 PM
Study NCT ID:
NCT04156659
Status:
WITHDRAWN
Last Update Posted:
2023-03-09
First Post:
2019-10-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Tisagenlecleucel in Chinese Pediatric and Young Adult Subjects With Relapsed or Refractory B-cell ALL
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-11-30
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-11-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-11-30
Completion Date Type:
ESTIMATED
First Submit Date:
2019-10-23
First Submit QC Date:
None
Study First Post Date:
2019-11-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-07
Last Update Post Date:
2023-03-09
Last Update Post Date Type:
ACTUAL